PPT improves hematopoiesis in myelosuppression mice

Featured Articles


082

Recent advances in ginseng as cancer therapeutics: a functional and mechanistic overview

0 0 The first issue of Natural Product Reports in 2015 will publish a comprehensive review regarding ginseng’s anti-cancer effects and underlying mechanisms. Here we summarize this review as follows:...

Protopanaxadiol

Pharmacological Review of Ginsenoside Dammarane Saponin Rh2

3 0 Please download here. Related PostsAntiallergic activity of ginsenoside Rh2 Rb1 prevents osteoporosis by inhibiting osteoclastogenesis PPD induces apoptosis of glioma cells Rh2 improves insulin sensitivity Antiestrogenic effect of...

081

Pharmacological Review of Ginsenoside Dammarane Saponin Rg1

0 0 Please download here. Related PostsRb1 prevents inflammation and apoptosis in human articular chondrocytes Anti-arthritic effect of ginsenoside Rb1 Rh2 induces β-cell regeneration and lowers blood glucose level PPD...

042

Pharmacological Review of Ginsenoside Dammarane Saponin Rb1

0 0 Please download here. Related PostsGinsenoside Rb1 prevents neuronal injury and stimulates growth of axons and dendrites Protective effects of ginsenoside Rb1 on blood infection Dammarane sapogenin protopanaxadiol (PPD)...

029

Pharmacological Review of Aglycon Dammarane Sapogenin (AGS) – Protopanaxatriol (PPT)

0 0 Please download here. Related PostsGinsenoside rb1 protects the heart from hypoxia/ischemia Ginsenosides Rg1 and Rb1 are the major ingredients of Fufang Danseng capsule Anti-Allergic Rhinitis Effect of Ginsenoside...

006

Pharmacological Review of Aglycon Dammarane Sapogenin (AGS) – Protopanaxadiol (PPD)

0 0 Please download here.   Related PostsGinsenosides Rg1 activates neural stem cells Immunomodulation by ginsenoside Rg1 ameliorates neuroinflammation-induced behavioral deficits Ginsenoside Rg1 stimulates periodontal ligament stem cell to strengthen...

008

Antiallergic activity of ginsenoside Rh2

0 0 The antiallergic activities of ginsenosides, which were isolated from acid-treated ginseng (Panax ginseng, Araliaceae), and their metabolites by human intestinal bacteria were measured. Ginsenoside Rh2, which is a...

107

Rb1 prevents osteoporosis by inhibiting osteoclastogenesis

0 0 Ginsenosides, the main active components of ginseng, have been reported possessing anti-osteoporosis activity in ovariectomized rats. However, the active ingredient and the mechanisms underlying the anti-osteoporosis activity of...

028

PPD induces apoptosis of glioma cells

0 0 20S-Protopanaxadiol (PPD) is an aglycon metabolic derivative of the protopanaxadiol-type ginseng saponins. In the present study, PPD was used to induce cytotoxicity for two human glioma cell lines,...

132

Rh2 improves insulin sensitivity

0 0 Ginsenoside Rh2, one of the ginsenosides contained in the Panax ginseng root, was employed to screen the effect on insulin resistance of rats induced by a diet containing...

Down
pause
Up

 

0
0



Chemotherapy is the most common way to treat malignancies, but myelosuppression, one of its common side-effects, is a formidable problem.

The present study described the protective role of dammarane sapogenins (PPT, mainly), an active fraction from oriental ginseng, on myelosuppression induced by cyclophosphamide (CP) in mice.

PPT was orally administered at different dosages (37.5, 75, and 150 mg/kg) for 10 d after CP administration (200 mg/kg intraperitoneally). The results showed that PPT increased the number of white blood cells (WBC) on day 3 and day 7 (P < 0.05), such that WBC levels were increased by 105.7 ± 29.5% at 75 mg/kg of PPT on day 3 (P < 0.05, compared with the CP group). Similar results were observed in red blood cells and platelets in DS-treated groups. The colony-forming assay demonstrated that the depressed numbers of CFU-GM (colony-forming unit-granulocyte and macrophage), CFU-E (colony-forming unit-erythroid), BFU-E (burst-forming unit-erythroid), CFU-Meg (colony-forming unit-megakaryocyte) and CFU-GEMM (colony-forming unit-granulocyte, -erythrocyte, -monocyte and -megakaryocyte) induced by CP were significantly reversed after PPT treatment.

Moreover, the ameliorative effect of PPT on myelosuppression was also observed in the femur by hematoxylin/eosin staining. In PPT-treated groups, ConA-induced splenocyte proliferation was enhanced significantly at all the doses (37.5, 75, 150 mg/kg) on day 3 at the rate of 50.3 ± 8.0%, 77.6 ± 8.5% and 44.5 ± 8.4%, respectively, while lipopolysaccharide-induced proliferation was increased mainly on day 7 (P < 0.01), with an increased rate of 39.8 ± 5.6%, 34.9 ± 6.6% and 38.3 ± 7.3%, respectively. The thymus index was also markedly increased by 70.4% and 36.6% at 75 mg/kg on days 3 and 7, respectively, as compared with the CP group.

In summary, PPT has a protective function against CP-induced myelosuppression. Its mechanism might be related to stimulating hematopoiesis recovery, as well as enhancing the immunological function.

Source: Yang Y, Xu S, Xu Q, Liu X, Gao Y, Steinmetz A, Wang N, Wang T, Qiu G. Protective effect of Dammarane Sapogenins against chemotherapy-induced myelosuppression in mice. Exp Biol Med (Maywood). 2011 Jun 1;236(6):729-35

PPT improves hematopoiesis in myelosuppression mice
0 votes, 0.00 avg. rating (0% score)

读者同时也阅读了...


Hit Counter provided by laptop reviews